RICCI, FEDERICO
 Distribuzione geografica
Continente #
NA - Nord America 18.827
AS - Asia 3.381
EU - Europa 2.275
SA - Sud America 476
AF - Africa 388
OC - Oceania 279
Continente sconosciuto - Info sul continente non disponibili 5
Totale 25.631
Nazione #
US - Stati Uniti d'America 18.646
SG - Singapore 1.097
CN - Cina 614
RU - Federazione Russa 356
BR - Brasile 350
DE - Germania 326
IT - Italia 325
IN - India 306
AU - Australia 271
GB - Regno Unito 258
HK - Hong Kong 240
ID - Indonesia 231
UA - Ucraina 218
IE - Irlanda 213
VN - Vietnam 204
FR - Francia 166
SE - Svezia 89
MX - Messico 82
KR - Corea 77
PL - Polonia 77
JP - Giappone 74
CA - Canada 68
FI - Finlandia 67
GH - Ghana 63
BD - Bangladesh 62
PK - Pakistan 62
NG - Nigeria 61
PH - Filippine 56
ZA - Sudafrica 53
KE - Kenya 52
TR - Turchia 51
MY - Malesia 49
TH - Thailandia 46
EG - Egitto 40
NL - Olanda 40
TW - Taiwan 36
ET - Etiopia 34
IQ - Iraq 34
AR - Argentina 32
EC - Ecuador 22
SA - Arabia Saudita 20
NP - Nepal 19
BE - Belgio 18
ES - Italia 18
IR - Iran 17
CL - Cile 16
LT - Lituania 16
IL - Israele 15
CO - Colombia 14
AT - Austria 13
MU - Mauritius 13
PE - Perù 13
UG - Uganda 12
VE - Venezuela 12
KG - Kirghizistan 11
ZM - Zambia 11
MA - Marocco 10
PT - Portogallo 10
RO - Romania 10
MG - Madagascar 9
NO - Norvegia 9
KH - Cambogia 7
PY - Paraguay 7
UZ - Uzbekistan 7
EE - Estonia 6
MW - Malawi 6
NZ - Nuova Zelanda 6
AZ - Azerbaigian 5
BO - Bolivia 5
CH - Svizzera 5
CM - Camerun 5
CZ - Repubblica Ceca 5
GR - Grecia 5
GT - Guatemala 5
JM - Giamaica 5
JO - Giordania 5
LV - Lettonia 5
TZ - Tanzania 5
AE - Emirati Arabi Uniti 4
CR - Costa Rica 4
DK - Danimarca 4
DZ - Algeria 4
EU - Europa 4
MM - Myanmar 4
NI - Nicaragua 4
QA - Qatar 4
TN - Tunisia 4
AL - Albania 3
BH - Bahrain 3
DO - Repubblica Dominicana 3
GE - Georgia 3
KW - Kuwait 3
KZ - Kazakistan 3
PA - Panama 3
BG - Bulgaria 2
BT - Bhutan 2
BY - Bielorussia 2
DM - Dominica 2
LB - Libano 2
MO - Macao, regione amministrativa speciale della Cina 2
Totale 25.597
Città #
Woodbridge 4.670
Wilmington 4.383
Houston 4.366
Singapore 652
Fairfield 506
Ashburn 424
Ann Arbor 393
Chandler 377
San Jose 295
Seattle 247
Beijing 200
Dublin 198
Cambridge 197
Hong Kong 196
Jacksonville 186
Medford 160
New York 149
Dearborn 140
Los Angeles 108
Perth 99
Santa Clara 92
The Dalles 91
Rome 90
Council Bluffs 82
Ho Chi Minh City 73
Lawrence 73
Boardman 72
Moscow 70
Tokyo 64
Jakarta 63
Melbourne 54
Zhengzhou 53
Kraków 49
Lauterbourg 48
Buffalo 44
Hanoi 44
Sydney 44
Chennai 43
Munich 43
Nairobi 43
Accra 42
São Paulo 41
Bangkok 40
Dallas 33
San Diego 33
Milan 32
Chicago 29
Kuala Lumpur 27
Mülheim 26
Shanghai 25
London 24
Montreal 23
Malang 22
Orem 22
Waurn Ponds 22
Bengaluru 21
Menlo Park 21
San Francisco 21
Mexico City 20
Manchester 19
Manila 19
Cairo 18
Guangzhou 18
Helsinki 18
Lagos 18
Nuremberg 18
Phoenix 18
Brussels 17
Hyderabad 17
Abuja 16
Baghdad 16
Mumbai 16
North Bergen 16
Riyadh 16
Warsaw 16
Bodorgan 15
Shenzhen 15
Taipei 15
Johannesburg 14
Kansas City 14
Karachi 14
Kathmandu 14
Lahore 14
Nanjing 14
Pune 14
Rio de Janeiro 14
Birmingham 13
Denpasar 13
Dhaka 13
Frankfurt am Main 13
Istanbul 13
Toronto 13
Aksum 12
Boston 12
Delhi 12
Kolkata 12
New Delhi 12
Redondo Beach 12
Redwood City 12
Atlanta 11
Totale 20.311
Nome #
A literature review of hypertensive retinopathy: systemic correlations and new technologies 2.490
CLU "in and out": looking for a link. 578
Validity and limitations of the Nidek NT-4000 non-contact tonometer: a clinical study 523
Review of nutrient actions on age-related macular degeneration 509
Visual disability and quality of life in glaucoma patients 504
Electro-oculography in pigment dispersion syndrome 498
Assessment of the retinal posterior pole in dominant optic atrophy by spectral-domain optical coherence tomography and microperimetry. 494
Age-related macular degeneration: insights into inflammatory genes 491
Clusterin in stool: a new biomarker for colon cancer screening? 486
Automatic Segmentation of Posterior Pole Retinal Layers In Patients with Early Stage Glaucoma Using Spectral Domain Optical Coherence Tomography 486
Modulation of Ku70/80, clusterin/ApoJ isoforms and Bax expression in indocyanine-green-mediated photo-oxidative cell damage 472
Age-specific changes in the prevalence and management of optically correctable visual impairment between 1988 and 2000: the Ponza Eye Study 468
Modulation of Ku70/80, clusterin/ApoJ isoforms and Bax expression in indocyanine-green-mediated photo-oxidative cell damage 461
Neuroprotection: VEGF, IL-6, and clusterin: the dark side of the moon 459
Long-term functional and morphologic retinal changes after ranibizumab and photodynamic therapy in myopic choroidal neovascularization 455
The 12-year Incidence of Glaucoma and Glaucoma-related Visual Field Loss in Italy: The Ponza Eye Study 448
Verteporfin photodynamic therapy combined with intravitreal triamcinolone for choroidal neovascularization due to angioid streaks 448
Combined reduced fluence photodynamic therapy and intravitreal ranibizumab for polypoidal choroidal vasculopathy 448
Prevalence of blindness and low vision in an Italian population: A comparison with other European studies 445
Age-specific changes in the prevalence of best-corrected visual impairment in an italian population 444
Typing of ARMS2 and CFH in age-related macular degeneration: case-control study and assessment of frequency in the Italian population 443
Angioid streak-related choroidal neovascularization treated by intravitreal ranibizumab 440
Spectral domain optical coherence tomography findings in patients with acute syphilitic posterior placoid chorioretinopathy 439
Successful treatment of an overlapping choriocapillaritis between multifocal choroiditis and acute zonal occult outer retinpathy (AZOOR) with adalimumab (Humira™). 435
Compassionate use of intravitreal pegaptanib in patients with age-related macular degeneration 432
Evaluation of pupillary response to light in patients with glaucoma: a study using computerized pupillometry 431
Low contrast visual acuity in pseudophakic patients implanted with an anterior surface modified prolate intraocular lens 427
CLU "in and out": looking for a link 423
Prevalence and risk factors of vision impairment among children of employees of Telecom, Italy. 423
Incidence of visual loss in the Ponza Eye Study, Italy 422
Clusterin in stool: a new biomarker for colon cancer screening? 416
Assessing individual risk for AMD with genetic counseling, family history, and genetic testing 415
Nationwide incidence of endophthalmitis among the general population and the subjects at risk of endophthalmitis in Italy 413
Prevalence and incidence of age-related cataract in a population sample from Priverno, Italy. Ophthalmic Epidemiol. 1999 Jun;6(2):95-103. 413
Neuroprotection: VEGF, IL-6, and clusterin: the dark side of the moon 409
ICGA Guided Low-fluence Photodynamic Therapy Combined With PRN Ranibizumab For Active Polypoidal Choroidal Vasculopathy 402
Persistent epithelial defect after penetrating keratoplasty caused by adenoviral infectious keratitis 398
Haplotypes in IL-8 gene are associated to age-related macular degeneration: a case-control study 398
Evaluation of fixation stability using different targets with the MP1 microperimeter 392
Polymorphisms in ARMS2 (LOC387715) and LOXL1 genes in the Japanese with age-related macular degeneration 373
Monolateral Corectopia: considerations about associated myopia. A case report. 370
Indocyanine green angiography and optical coherence tomography angiography of choroidal neovascularization in age-related macular degeneration 338
L’epidemiologia del glaucoma 333
OLIMPIC: a 12-month study on the criteria driving retreatment with ranibizumab in patients with visual impairment due to myopic choroidal neovascularization 320
Moorfields Regression Analysis (MRA) and Glaucoma Probability Score (GPS) Agreement in Daily Clinical Practice 319
Towards the application of precision medicine in age-related macular degeneration 317
Ranibizumab 0.5 mg treat-and-extend regimen for diabetic macular oedema: The RETAIN study 291
The Interplay between miRNA-Related Variants and Age-Related Macular Degeneration: EVIDENCE of Association of MIR146A and MIR27A. 277
Uncovering genetic and non-genetic biomarkers specific for exudative age-related macular degeneration: Significant association of twelve variants 266
Using real-world data to estimate the Social Security Costs of Retinal Diseases: Results from the Observatory on Legal Blindness 244
Dual Antagonism of PDGF and VEGF in Neovascular Age-Related Macular Degeneration: A Phase IIb, Multicenter, Randomized Controlled Trial 236
Ultrasound-Guided Vacuum-Assisted Biopsy in Small Breast: A Cost-Saving Solution 211
TWELVE-MONTH OUTCOMES OF INTRAVITREAL AFLIBERCEPT FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: Fixed Versus As-needed Dosing 209
Bilateral Retinal Angiomatous Proliferation in a Variant of Retinitis Pigmentosa 202
Platelet-rich plasma as treatment for persistent ocular epithelial defects 166
Efficacy and safety of lampalizumab for geographic atrophy due to age-related macular degeneration: Chroma and Spectri phase 3 randomized clinical trials 102
Thickness mapping of individual retinal layers and sectors by Spectralis Spectral Domain-optical Coherence Tomography in Autosomal Dominant Optic Atrophy 100
Angiopoietin/Tie2 signalling and its role in retinal and choroidal vascular diseases: a review of preclinical data 96
A cluster of presumed, noninfectious endophthalmitis after intravitreal injection of bevacizumab: long-term follow-up 93
Antimicrobial activity on contact lenses contaminated with planktonic and sessile forms of bacteria: An experimental approach 92
Definition of indicators of appropriateness in the management of neovascular age-related macular degeneration: An expert opinion 88
Optical coherence tomography angiography in the multimodal assessment of the retinal posterior pole in autosomal dominant optic atrophy 88
Epigenomic signatures in age-related macular degeneration: Focus on their role as disease modifiers and therapeutic targets 85
Ranibizumab for visual impairment due to diabetic macular edema: Real-world evidence in the Italian population (pride study) 84
Aflibercept in persistent neovascular AMD: Comparison of different treatment strategies in switching therapy 84
Genetic determinants highlight the existence of shared etiopathogenetic mechanisms characterizing age-related macular degeneration and neurodegenerative disorders 79
Effectiveness of anti-vascular endothelial growth factors in neovascular age-related macular degeneration and variables associated with visual acuity outcomes: Results from the EAGLE study 73
Placental growth factor and its potential role in diabetic retinopathy and other ocular neovascular diseases 71
Safety and tolerability of ranibizumab in uni/bilateral neovascular age-related macular degeneration: 12-month TWEYEs study 69
An optical coherence tomography-based grading of diabetic maculopathy proposed by an international expert panel: The European School for Advanced Studies in Ophthalmology classification 68
Efficacy and safety of avacincaptad pegol in patients with geographic atrophy (GATHER2): 12-month results from a randomised, double-masked, phase 3 trial 67
Efficacy and Safety of Biosimilar FYB201 Compared with Ranibizumab in Neovascular Age-Related Macular Degeneration 63
Management of diabetic macular edema with intravitreal dexamethasone implants: Expert recommendations using a Delphi-based approach 63
Vision-Related Quality of Life in Patients with Diabetic Macular Edema Treated with Intravitreal Aflibercept: The AQUA Study 62
Neovascular age-related macular degeneration: Therapeutic management and new-upcoming approaches 61
Paper card-like electrochemical platform as a smart point-of-care device for reagent-free glucose measurement in tears 58
Longitudinal Structural and Functional Evaluation of Dark-without-Pressure Fundus Lesions in Patients with Autoimmune Diseases 54
Fluid as a critical biomarker in neovascular age-related macular degeneration management: literature review and consensus recommendations 54
Dosing Regimens of Intravitreal Aflibercept for Diabetic Macular Edema Beyond the First Year: VIOLET, a Prospective Randomized Trial 36
Correction: Save our Sight (SOS): a collective call-to-action for enhanced retinal care across health systems in high income countries (Eye, (2023), 37, 16, (3351-3359), 10.1038/s41433-023-02540-w) 35
Totale 25.875
Categoria #
all - tutte 62.686
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.686


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202133 0 0 0 0 0 0 0 0 0 0 0 33
2021/2022703 14 42 46 26 12 55 120 30 36 53 83 186
2022/2023962 105 81 24 100 104 211 75 93 84 2 60 23
2023/20241.066 91 45 70 71 99 172 88 60 70 72 49 179
2024/20252.751 132 428 270 145 150 191 247 204 276 205 291 212
2025/20263.880 395 159 458 413 290 183 353 500 485 285 225 134
Totale 25.875